Placebo News and Research

RSS

Levonorgestrel-piroxicam co-treatment shows promise as more effective emergency contraception

Taking piroxicam, an anti-inflammatory medication commonly used for arthritis pain, at the same time as the levonorgestrel emergency contraceptive pill after unprotected sex prevents significantly more pregnancies compared to taking levonorgestrel alone, according to a randomised controlled trial published in The Lancet.

17 Aug 2023

Natural bioactive molecules can relieve cold and flu symptoms

Researchers at Applied Biological Laboratories Inc. discovered how natural bioactive molecules can effectively relieve cold and flu symptoms by protecting the mucosal barrier function and reducing inflammation during these infections.

16 Aug 2023

Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?

Researchers evaluated the impact of convalescent serum therapy on all-cause mortality among COVID-19 patients.

14 Aug 2023

New Alzheimer’s drug raises hopes — along with questions

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.

11 Aug 2023

Low levels of vitamin K linked to poor lung function

People with low levels of vitamin K in their blood are more likely to have poor lung function and to say they suffer with asthma, chronic obstructive pulmonary disease (COPD) and wheezing, according to a study published today (Thursday) in ERJ Open Research.

9 Aug 2023

The safety of mesenchymal stem cell therapy for treating severe COVID-19

Normoxic-allogenic umbilical cord mesenchymal stem cells are safe and effective for treating severe COVID-19 patients.

7 Aug 2023

Small randomized controlled trial finds kombucha decreased fasting blood glucose in individuals with type 2 diabetes

A recent study evaluated the anti-hyperglycemic effects of kombucha tea in diabetic adults.

3 Aug 2023

Antidepressants may help prevent bipolar depression relapse

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia.

2 Aug 2023

What are the mediators linking cardiometabolic risk factors and severe COVID-19?

Researchers performed a genome-wide association study to explore whether biomarker levels are causally related to COVID-19 hospitalization.

2 Aug 2023

Does long-term, daily low-dose aspirin treatment affect the incidence of stroke or intracerebral bleeding?

Researchers found that older adults who took aspirin had a 38% higher risk of intracranial bleeding.

2 Aug 2023

Non-invasive brain stimulation shows promise for treating ADHD in children

Non-invasive brain stimulation, combined with cognitive training, could significantly improve symptoms of attention deficit hyperactivity disorder (ADHD) in children, according to new research jointly led by the University of Surrey and the Hebrew University of Jerusalem.

1 Aug 2023

Low-dose atropine eyedrops not effective in slowing myopia progression in children

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

1 Aug 2023

Kombucha may help lower blood sugar levels in people with type 2 diabetes

People with type-II diabetes who drank the fermented tea drink kombucha for four weeks had lower fasting blood glucose levels compared to when they consumed a similar-tasting placebo beverage, according to results from a clinical trial conducted by researchers at Georgetown University's School of Health, the University of Nebraska-Lincoln and MedStar Health.

1 Aug 2023

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.

31 Jul 2023

Scrambler therapy: A new non-invasive treatment for chronic pain

A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately 80%–90% of patients with chronic pain, and it may be more effective than another noninvasive therapy: transcutaneous electrical nerve stimulation (TENS).

31 Jul 2023

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

31 Jul 2023

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2023.

31 Jul 2023

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

27 Jul 2023

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer's disease and concerns about episodes of memory decline, according to a UCLA Health study.

26 Jul 2023

Placebo News and Research

Levonorgestrel-piroxicam co-treatment shows promise as more effective emergency contraception

Natural bioactive molecules can relieve cold and flu symptoms

Does convalescent serum treatment lower mortality in SARS-CoV-2-infected individuals?

New Alzheimer’s drug raises hopes — along with questions

Low levels of vitamin K linked to poor lung function

The safety of mesenchymal stem cell therapy for treating severe COVID-19

Small randomized controlled trial finds kombucha decreased fasting blood glucose in individuals with type 2 diabetes

Antidepressants may help prevent bipolar depression relapse

What are the mediators linking cardiometabolic risk factors and severe COVID-19?

Does long-term, daily low-dose aspirin treatment affect the incidence of stroke or intracerebral bleeding?

Non-invasive brain stimulation shows promise for treating ADHD in children

Low-dose atropine eyedrops not effective in slowing myopia progression in children

Kombucha may help lower blood sugar levels in people with type 2 diabetes

RSV vaccines for older adults: 2023 ACIP recommendations

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Scrambler therapy: A new non-invasive treatment for chronic pain

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News